Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) — Sustainability Report | 27 August 2026

· BSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Jagsonpal Pharmaceuticals filed its BRSR report with BSE and NSE on August 27, 2026, for FY 2025-26.
💡 Investor Takeaway
The BRSR filing confirms regulatory compliance and ESG commitment, but provides no financial guidance or future performance outlook for investors.

Jagsonpal Pharmaceuticals Limited submitted its Business Responsibility and Sustainability Report (BRSR) for FY 2025-26 to BSE and NSE on August 27, 2026, as mandated under SEBI LODR Regulation 34(2)(f). The standalone report details ESG disclosures across governance, environmental impact, social initiatives, and stakeholder engagement. It highlights zero material non-compliance, robust whistleblower mechanisms, and focus on patient safety and inclusive growth. The filing confirms adherence to National Guidelines on Responsible Business Conduct (NGRBC) principles, with no subsidiaries but an 85% stake in Aequitas Healthcare Pvt Ltd. No financial figures or performance metrics beyond operational disclosures are provided in the BRSR extract.

📄 View Original Announcement (PDF)

About Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹1,586.96 Cr P/E: 35.5 ROE: 19.0% ROCE: 25.8% Div Yield: 1.66%

View full JAGSNPHARM stock details →

📡 Get AI alerts when JAGSNPHARM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track JAGSNPHARM — Free

📊 More JAGSNPHARM filings

See all JAGSNPHARM filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when JAGSNPHARM files new disclosures

Track JAGSNPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track JAGSNPHARM — Free

Free account · 2 AI queries/day